VRNA Insider Trading

Insider Ownership Percentage: 4.80%
Insider Buying (Last 12 Months): $378,874.24
Insider Selling (Last 12 Months): $5,063,998.08

Verona Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Verona Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Verona Pharma Share Price & Price History

Current Price: $37.49
Price Change: Price Decrease of -0.9 (-2.34%)
As of 11/6/2024 05:06 PM ET

This chart shows the closing price history over time for VRNA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Verona Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/4/2024David ZaccardelliCEOSell94,144$4.39$413,292.1615,204,752View SEC Filing Icon  
11/4/2024Mark W. HahnCFOSell80,784$4.39$354,641.7614,293,736View SEC Filing Icon  
11/1/2024David ZaccardelliCEOSell46,888$4.38$205,369.4415,298,896View SEC Filing Icon  
11/1/2024Mark W. HahnCFOSell48,888$4.38$214,129.4414,374,520View SEC Filing Icon  
10/25/2024David ZaccardelliCEOSell4,800$4.38$21,024.0014,591,736View SEC Filing Icon  
10/24/2024Mark W. HahnCFOSell141,360$4.38$619,156.8013,672,560View SEC Filing Icon  
10/23/2024David ZaccardelliCEOSell16$4.38$70.0814,736,536View SEC Filing Icon  
10/21/2024David ZaccardelliCEOSell110,456$4.38$483,797.2814,894,464View SEC Filing Icon  
10/21/2024Mark W. HahnCFOSell116,696$4.38$511,128.4813,973,264View SEC Filing Icon  
10/18/2024David ZaccardelliCEOSell245,784$4.38$1,076,533.9215,004,920View SEC Filing Icon  
10/18/2024Mark W. HahnCFOSell249,728$4.38$1,093,808.6414,089,960View SEC Filing Icon  
5/3/2024Kathleen A. RickardInsiderSell36,248$1.96$71,046.082,621,552View SEC Filing Icon  
11/20/2023Martin EdwardsDirectorBuy33,736$1.84$62,074.24144,800View SEC Filing Icon  
11/6/2023David R. EbsworthDirectorBuy160,000$1.98$316,800.00844,643View SEC Filing Icon  
11/3/2023Kathleen A. RickardInsiderSell58,752$1.92$112,803.842,840,640View SEC Filing Icon  
8/7/2023Claire PollGeneral CounselSell1,512$2.47$3,734.641,907,367View SEC Filing Icon  
8/7/2023David ZaccardelliCEOSell8,616$2.47$21,281.5216,431,800View SEC Filing Icon  
8/7/2023Kathleen A. RickardInsiderSell1,600$2.47$3,952.002,872,528View SEC Filing Icon  
8/4/2023David ZaccardelliCEOSell150,000$2.50$375,000.0016,440,416View SEC Filing Icon  
8/3/2023Claire PollGeneral CounselSell20,608$2.54$52,344.321,935,231View SEC Filing Icon  
8/3/2023Kathleen A. RickardInsiderSell50,600$2.55$129,030.002,902,072View SEC Filing Icon  
8/3/2023Mark W. HahnCFOSell117,272$2.54$297,870.8815,679,864View SEC Filing Icon  
8/2/2023David ZaccardelliCEOSell73,704$2.59$190,893.3616,707,688View SEC Filing Icon  
8/1/2023Claire PollGeneral CounselSell18,608$2.68$49,869.441,968,783View SEC Filing Icon  
8/1/2023Kathleen A. RickardInsiderSell19,736$2.68$52,892.482,966,400View SEC Filing Icon  
8/1/2023Mark W. HahnCFOSell105,944$2.68$283,929.9215,870,840View SEC Filing Icon  
5/15/2023Orbimed Advisors LlcDirectorSell359,713$20.08$7,223,037.043,777,778View SEC Filing Icon  
5/11/2023Orbimed Advisors LlcDirectorSell80,000$22.26$1,780,800.004,180,691View SEC Filing Icon  
5/3/2023Kathleen A. RickardInsiderSell28,752$2.65$76,192.802,971,136View SEC Filing Icon  
5/1/2023Claire PollGeneral CounselSell80,376$2.58$207,370.081,979,063View SEC Filing Icon  
5/1/2023David ZaccardelliCEOSell455,536$2.58$1,175,282.8816,887,336View SEC Filing Icon  
5/1/2023Kathleen A. RickardInsiderSell77,424$2.58$199,753.922,999,888View SEC Filing Icon  
5/1/2023Mark W. HahnCFOSell455,528$2.58$1,175,262.2415,976,784View SEC Filing Icon  
2/1/2023Claire PollGeneral CounselSell152,000$2.59$393,680.00774,256View SEC Filing Icon  
2/1/2023David ZaccardelliCEOSell432,928$2.56$1,108,295.6817,342,872View SEC Filing Icon  
2/1/2023Kathleen A. RickardInsiderSell89,960$2.56$230,297.603,106,064View SEC Filing Icon  
2/1/2023Mark W. HahnCFOSell413,168$2.56$1,057,710.0816,432,312View SEC Filing Icon  
12/22/2022Claire PollGeneral CounselSell240,000$2.69$645,600.00774,256View SEC Filing Icon  
12/22/2022Orbimed Advisors LlcDirectorSell3,969,496$21.77$86,415,927.9236,255,896View SEC Filing Icon  
12/20/2022David ZaccardelliCEOSell600,000$2.12$1,272,000.0017,775,800View SEC Filing Icon  
8/9/2022David ZaccardelliCEOSell600,000$1.75$1,050,000.0015,263,560View SEC Filing Icon  
8/2/2022Kathleen A. RickardInsiderSell28,752$0.70$20,126.402,376,040View SEC Filing Icon  
8/1/2022David ZaccardelliCEOSell32,904$0.70$23,032.8015,863,560View SEC Filing Icon  
8/1/2022Mark W. HahnCFOSell13,168$0.70$9,217.6014,913,496View SEC Filing Icon  
5/3/2022David ZaccardelliCEOSell32,904$0.50$16,452.0016,351,328View SEC Filing Icon  
5/3/2022Kathleen A. RickardInsiderSell28,752$0.49$14,088.482,461,224View SEC Filing Icon  
5/3/2022Mark W. HahnCFOSell12,512$0.50$6,256.0015,381,520View SEC Filing Icon  
4/11/2022Kathleen A. RickardInsiderSell59,720$0.54$32,248.802,546,408View SEC Filing Icon  
4/8/2022Kathleen A. RickardInsiderSell112,800$0.59$66,552.002,606,128View SEC Filing Icon  
2/3/2022David ZaccardelliCEOSell52,056$0.73$38,000.88View SEC Filing Icon  
2/2/2022Mark W. HahnCFOSell10,416$0.76$7,916.16View SEC Filing Icon  
2/1/2022Lisa DeschampsDirectorSell11,664$0.78$9,097.92View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Verona Pharma (NASDAQ:VRNA)

85.88% of Verona Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VRNA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Verona Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/5/2024Verus Capital Partners LLC11,320$0.33M0.0%-34.9%0.014%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP29,513$0.85M0.1%N/A0.036%Search for SEC Filing on Google Icon
11/4/2024Crossmark Global Holdings Inc.16,150$0.47M0.0%N/A0.020%Search for SEC Filing on Google Icon
11/1/2024Atria Investments Inc19,054$0.55M0.0%N/A0.024%Search for SEC Filing on Google Icon
11/1/2024Cahill Wealth Management LLC7,745$0.22M0.1%N/A0.010%Search for SEC Filing on Google Icon
10/30/2024Rosalind Advisors Inc.275,000$7.91M5.0%+10.0%0.344%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC50,000$1.44M1.1%-10.7%0.063%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC985,076$28.34M1.5%+4.8%1.213%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE21,955$0.63M0.0%-8.3%0.027%Search for SEC Filing on Google Icon
10/25/2024Diversify Wealth Management LLC21,254$0.61M0.1%N/A0.027%Search for SEC Filing on Google Icon
10/25/2024AMI Asset Management Corp66,346$1.91M0.1%-5.2%0.083%Search for SEC Filing on Google Icon
10/25/2024Diversify Advisory Services LLC5,861$0.17M0.0%N/A0.007%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.21,041$0.61M0.1%+37.1%0.026%Search for SEC Filing on Google Icon
10/24/2024PFG Investments LLC36,800$1.06M0.1%-17.5%0.045%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.2,610$75K0.0%+25.4%0.003%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.17,174$0.49M0.3%N/A0.021%Search for SEC Filing on Google Icon
10/23/2024Moody Aldrich Partners LLC252,752$7.27M1.3%-14.6%0.316%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.155,835$4.48M0.2%+14.9%0.195%Search for SEC Filing on Google Icon
10/17/2024Claro Advisors LLC7,273$0.21M0.0%N/A0.009%Search for SEC Filing on Google Icon
10/7/2024GAMMA Investing LLC1,336$38K0.0%+70.6%0.002%Search for SEC Filing on Google Icon
8/27/2024Clearbridge Investments LLC405,819$5.87M0.0%+58.8%0.508%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC2,433,725$35.19M0.8%-35.3%3.011%Search for SEC Filing on Google Icon
8/16/2024Quarry LP2,000$29K0.0%-63.6%0.002%Search for SEC Filing on Google Icon
8/16/2024Frazier Life Sciences Management L.P.3,314,349$47.93M2.2%+10.0%4.101%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company59,418$0.86M0.0%N/A0.074%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC527,640$7.63M0.0%+4.7%0.653%Search for SEC Filing on Google Icon
8/15/2024Maverick Capital Ltd.3,092,807$44.72M0.8%+74.2%3.827%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC700,000$10.12M1.2%-14.4%0.866%Search for SEC Filing on Google Icon
8/15/2024Alerce Investment Management L.P.213,000$3.08M6.0%N/A0.264%Search for SEC Filing on Google Icon
8/14/2024NEA Management Company LLC5,584,753$80.76M6.1%+9.3%6.910%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP13,500$0.20M0.0%N/A0.017%Search for SEC Filing on Google Icon
8/14/2024Hood River Capital Management LLC1,062,456$15.36M0.3%+7.6%1.315%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.66,781$0.97M0.0%-10.1%0.083%Search for SEC Filing on Google Icon
8/12/2024Resolute Capital Asset Partners LLC50,000$0.72M0.4%N/A0.062%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC31,044$0.45M0.0%N/A0.038%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.2,163,600$31.29M0.1%-4.2%2.677%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.878,043$12.70M0.0%+56.6%1.105%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC939,576$13.59M0.8%+39.0%1.182%Search for SEC Filing on Google Icon
8/7/2024PFG Investments LLC44,600$0.65M0.0%+67.7%0.055%Search for SEC Filing on Google Icon
8/6/2024Candriam S.C.A.772,997$11.18M0.1%N/A0.956%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc121,600$1.76M0.0%N/A0.150%Search for SEC Filing on Google Icon
8/1/2024Verus Capital Partners LLC17,385$0.25M0.0%N/A0.022%Search for SEC Filing on Google Icon
7/30/2024Matisse Capital34,400$0.50M0.2%+77.3%0.043%Search for SEC Filing on Google Icon
7/29/2024EMC Capital Management2,500$38K0.0%N/A0.003%Search for SEC Filing on Google Icon
7/26/2024Legato Capital Management LLC10,670$0.15M0.0%N/A0.013%Search for SEC Filing on Google Icon
7/25/2024AMI Asset Management Corp70,000$1.01M0.1%N/A0.087%Search for SEC Filing on Google Icon
7/20/2024Hennion & Walsh Asset Management Inc.135,629$1.96M0.1%+101.3%0.171%Search for SEC Filing on Google Icon
7/10/2024CWM LLC2,000$29K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC23,180$0.37M0.0%N/A0.029%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC375,310$6.04M0.7%+2.1%0.464%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC2,031,994$32.66M0.0%+12.7%2.514%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC123,215$1.98M0.0%-25.6%0.152%Search for SEC Filing on Google Icon
5/15/2024Bellevue Group AG1,139,295$18.33M0.3%+35.6%1.410%Search for SEC Filing on Google Icon
5/15/2024Hood River Capital Management LLC987,756$15.89M0.4%+4.3%1.222%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC817,833$13.16M1.7%+45.1%1.035%Search for SEC Filing on Google Icon
5/14/2024CM Management LLC35,000$0.56M0.5%N/A0.043%Search for SEC Filing on Google Icon
5/13/2024Clearbridge Investments LLC255,609$4.11M0.0%+2.7%0.316%Search for SEC Filing on Google Icon
5/8/2024US Bancorp DE23,822$0.38M0.0%-43.4%0.029%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.74,294$1.20M0.0%+3.7%0.092%Search for SEC Filing on Google Icon
5/2/2024Jennison Associates LLC1,593,833$25.65M0.0%+0.5%1.972%Search for SEC Filing on Google Icon
5/1/2024Capstone Investment Advisors LLC25,616$0.41M0.0%N/A0.032%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets23,412$0.38M0.0%+1,054.4%0.029%Search for SEC Filing on Google Icon
5/1/2024Matisse Capital19,400$0.31M0.2%N/A0.024%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.20,200$0.33M0.0%+35.8%0.025%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC675,757$10.87M0.6%+44.1%0.836%Search for SEC Filing on Google Icon
4/22/2024PFG Investments LLC26,600$0.43M0.0%+49.4%0.033%Search for SEC Filing on Google Icon
4/22/2024Vivo Capital LLC3,610,177$58.09M4.6%-15.1%4.467%Search for SEC Filing on Google Icon
4/17/2024Hennion & Walsh Asset Management Inc.67,365$1.08M0.1%+71.4%0.083%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP3,783,994$75.23M0.0%-15.3%4.734%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC3,866,214$76.86M1.7%-3.5%4.836%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC1,377,781$27.39M0.4%+62.1%1.724%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC504,742$10.03M1.4%+20.8%0.631%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP780,900$15.52M0.6%-5.9%0.977%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP124,040$2.47M1.8%N/A0.155%Search for SEC Filing on Google Icon
2/14/2024Artia Global Partners LP130,790$2.60M0.8%N/A0.164%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG839,996$16.70M0.3%-1.9%1.051%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC4,495$89K0.0%+950.2%0.006%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC563,824$11.21M2.1%+53.1%0.705%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC50,836$1.01M0.1%+1.7%0.064%Search for SEC Filing on Google Icon
2/12/20241492 Capital Management LLC166,038$3.30M1.9%+1.0%0.220%Search for SEC Filing on Google Icon
2/12/2024Cape Investment Advisory Inc.2,001$40K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/9/2024US Bancorp DE42,102$0.84M0.0%-23.4%0.053%Search for SEC Filing on Google Icon
2/9/2024D.A. Davidson & CO.33,400$0.66M0.0%+2.8%0.042%Search for SEC Filing on Google Icon
2/9/2024Clearbridge Investments LLC248,964$4.95M0.0%N/A0.311%Search for SEC Filing on Google Icon
2/8/2024Nicholas Investment Partners LP169,126$3.36M0.4%-85.5%0.212%Search for SEC Filing on Google Icon
2/8/2024First Turn Management LLC1,206,291$23.98M3.4%N/A1.509%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC11,350$0.23M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund29,669$0.59M0.0%+14.3%0.037%Search for SEC Filing on Google Icon
2/1/2024Jennison Associates LLC1,585,385$31.52M0.0%+9.9%1.983%Search for SEC Filing on Google Icon
1/26/2024Moody Aldrich Partners LLC321,161$6.39M1.1%-9.5%0.402%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.14,878$0.30M0.1%-73.3%0.019%Search for SEC Filing on Google Icon
1/17/2024PFG Investments LLC17,800$0.35M0.1%N/A0.022%Search for SEC Filing on Google Icon
1/16/2024Legato Capital Management LLC24,329$0.48M0.1%+26.1%0.030%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP4,467,571$72.82M0.0%+3.8%5.589%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.280,126$4.57M0.0%N/A0.350%Search for SEC Filing on Google Icon
11/15/2023Kennedy Capital Management LLC139,601$2.28M0.1%+19.2%0.022%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.426,931$6.96M0.0%+95.1%0.067%Search for SEC Filing on Google Icon
11/15/2023Affinity Asset Advisors LLC368,329$6M1.7%-17.7%0.058%Search for SEC Filing on Google Icon
11/15/2023Glenmede Trust Co. NA39,005$0.64M0.0%-12.3%0.006%Search for SEC Filing on Google Icon
11/14/2023Eventide Asset Management LLC850,000$13.86M0.2%N/A0.134%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Verona Pharma logo
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.
Read More on Verona Pharma

Today's Range

Now: $37.49
Low: $36.74
High: $38.56

50 Day Range

MA: $31.07
Low: $26.01
High: $38.39

52 Week Range

Now: $37.49
Low: $11.39
High: $39.40

Volume

741,600 shs

Average Volume

922,301 shs

Market Capitalization

$3.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of Verona Pharma?

Verona Pharma's top insider shareholders include:
  1. Orbimed Advisors Llc (Director)
  2. David Zaccardelli (CEO)
  3. Mark W Hahn (CFO)
  4. Kathleen A Rickard (Insider)
  5. Claire Poll (General Counsel)
  6. David R Ebsworth (Director)
  7. Martin Edwards (Director)
Learn More about top insider investors at Verona Pharma.

Who are the major institutional investors of Verona Pharma?

Verona Pharma's top institutional investors include:
  1. Rice Hall James & Associates LLC — 1.21%
  2. Rosalind Advisors Inc. — 0.34%
  3. Moody Aldrich Partners LLC — 0.32%
  4. Hennion & Walsh Asset Management Inc. — 0.19%
  5. AMI Asset Management Corp — 0.08%
  6. AlphaCentric Advisors LLC — 0.06%
Learn More about top institutional investors of Verona Pharma stock.

Which major investors are selling Verona Pharma stock?

Within the previous quarter, VRNA stock was sold by these institutional investors:
  1. Moody Aldrich Partners LLC
  2. PFG Investments LLC
  3. Verus Capital Partners LLC
  4. AlphaCentric Advisors LLC
  5. AMI Asset Management Corp
  6. US Bancorp DE
Within the last year, company insiders that have sold Verona Pharma company stock include:
  1. Orbimed Advisors Llc (Director)
  2. David Zaccardelli (CEO)
  3. Mark W Hahn (CFO)
Learn More investors selling Verona Pharma stock.

Which major investors are buying Verona Pharma stock?

In the last quarter, VRNA stock was bought by institutional investors including:
  1. Rice Hall James & Associates LLC
  2. GSA Capital Partners LLP
  3. Rosalind Advisors Inc.
  4. Diversify Wealth Management LLC
  5. Hennion & Walsh Asset Management Inc.
  6. Atria Investments Inc
  7. Values First Advisors Inc.
  8. Crossmark Global Holdings Inc.
Within the last year, these company insiders have bought Verona Pharma stock:
  1. Orbimed Advisors Llc (Director)
  2. David Zaccardelli (CEO)
Learn More investors buying Verona Pharma stock.